China Gives Conditional Approval For Pfizer COVID Pill Paxlovid
Feb 15, 2022 ·
56s
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
China says it has given conditional approval for Pfizer’s COVID-19 drug Paxlovid to treat adults with mild to moderate illness and a high risk of developing severe disease. Pfizer says...
show more
China says it has given conditional approval for Pfizer’s COVID-19 drug Paxlovid to treat adults with mild to moderate illness and a high risk of developing severe disease.
Pfizer says that preliminary studies show that Paxlovid does not target the ever-evolving spike protein the coronavirus uses to invade cells, meaning it should theoretically be more variant-proof.
China’s National Medical Products Administration says further research on the drug needed to be undertaken and submitted to the regulator.
Beijing has not yet approved any foreign-made coronavirus vaccines.
show less
Pfizer says that preliminary studies show that Paxlovid does not target the ever-evolving spike protein the coronavirus uses to invade cells, meaning it should theoretically be more variant-proof.
China’s National Medical Products Administration says further research on the drug needed to be undertaken and submitted to the regulator.
Beijing has not yet approved any foreign-made coronavirus vaccines.
Information
Author | Africa Business Radio |
Organization | Africa Business Radio |
Website | - |
Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company